CSRNP2
Cysteine/serine-rich nuclear protein 2
Also known as: C12ORF2, C12orf22, CSRN2_HUMAN, FAM130A1, PPP1R72, TAIP-12
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H175
- Gene
- CSRNP2
- Ensembl
- ENSG00000110925
- Chromosome
- 12
- Canonical length
- 543 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nuclear speckles
OverviewNCBI Gene
The protein encoded by this gene belongs to the CSRNP family of nuclear proteins that share conserved regions, including cysteine- and serine- rich regions, a basic domain, a transcriptional activation domain, and bind the sequence 'AGAGTG', thus have the hallmark of transcription factors. Studies in mice suggest that these genes may have redundant functions. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
543 residues, UniProt reviewed canonical sequence.
>Q9H175|CSRNP2
1 MDAFTGSGLK RKFDDVDVGS SVSNSDDEIS SSDSADSCDS LNPPTTASFT PTSILKRQKQ
61 LRRKNVRFDQ VTVYYFARRQ GFTSVPSQGG SSLGMAQRHN SVRSYTLCEF AQEQEVNHRE
121 ILREHLKEEK LHAKKMKLTK NGTVESVEAD GLTLDDVSDE DIDVENVEVD DYFFLQPLPT
181 KRRRALLRAS GVHRIDAEEK QELRAIRLSR EECGCDCRLY CDPEACACSQ AGIKCQVDRM
241 SFPCGCSRDG CGNMAGRIEF NPIRVRTHYL HTIMKLELES KRQVSRPAAP DEEPSPTASC
301 SLTGAQGSET QDFQEFIAEN ETAVMHLQSA EELERLKAEE DSSGSSASLD SSIESLGVCI
361 LEEPLAVPEE LCPGLTAPIL IQAQLPPGSS VLCFTENSDH PTASTVNSPS YLNSGPLVYY
421 QVEQRPVLGV KGEPGTEEGS ASFPKEKDLN VFSLPVTSLV ACSSTDPAAL CKSEVGKTPT
481 LEALLPEDCN PEEPENEDFH PSWSPSSLPF RTDNEEGCGM VKTSQQNEDR PPEDSSLELP
541 LAVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CSRNP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.57
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- testis: 25 nTPM
- cerebellum: 23 nTPM
- cerebral cortex: 21 nTPM
- retina: 19 nTPM
- pituitary gland: 17 nTPM
- hypothalamus: 16 nTPM
Single-cell type
- tuft cells: 138 nCPM
- cardiomyocytes: 106 nCPM
- colonocytes: 74 nCPM
- epididymal basal cells: 63 nCPM
- epicardial cells: 52 nCPM
- choroid plexus epithelial cells: 52 nCPM
Immune cell
- NK-cell: 2.3 nTPM
- eosinophil: 1 nTPM
- naive CD8 T-cell: 1 nTPM
- neutrophil: 1 nTPM
- gdT-cell: 0.7 nTPM
- memory CD4 T-cell: 0.7 nTPM
Brain region
- cerebral cortex: 55 nTPM
- hypothalamus: 50 nTPM
- hippocampal formation: 49 nTPM
- basal ganglia: 49 nTPM
- thalamus: 45 nTPM
- white matter: 43 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.33
- gnomAD pLI
- 0.96
- gnomAD missense Z
- 2.17
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- positive regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- phosphatase binding
- sequence-specific DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CSRNP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CSRNP2 as an antibody target. Whether an autoantibody or antibody against CSRNP2 could matter depends on whether native CSRNP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CSRNP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CSRNP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...